Loading organizations...
§ Private Profile · Cardiff By The Sea, CA, USA
Medical device company developing next-gen PFA technology for electrophysiologists, focused on complex cardiac arrhythmias.
Based in California, Field Medical was founded in 2022 by Dr. Steven Mickelsen to develop next-generation pulsed field ablation technology treating complex cardiac arrhythmias, including ventricular and supraventricular tachycardia. The company's proprietary FieldForce system utilizes FieldBending technology to concentrate therapeutic effects and minimize unwanted side effects, targeting the growing $3.6 billion cardiac catheter ablation market. The device recently received breakthrough designation from the FDA, entered the agency's total product life cycle advisory program, and presented first-in-human data at the Heart Rhythm Society meeting. To advance the system toward commercial readiness and fund pilot studies, the enterprise secured a $40 million Series A financing round, following an oversubscribed seed round led by Tajar Varghese. The executive team includes Chief Financial Officer Oskar Dadason and builds upon Mickelsen’s prior success with FARAPULSE, which Boston Scientific acquired for over $460 million.
Field Medical has raised $89.0M across 3 funding rounds.
Field Medical has raised $89.0M in total across 3 funding rounds.
Field Medical has raised $89.0M across 3 funding rounds. Most recently, it raised $35.0M Series B in July 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 1, 2025 | $35M Series B | Louis A Cannon, MD, Faca, Facc, Facp, Fscai, BEN Cannon | — | Announced |
| Apr 22, 2025 | $40M Series A | — | — | Announced |
| Sep 18, 2023 | $14M Seed | — | — | Announced |
Field Medical has raised $89.0M in total across 3 funding rounds.
Field Medical's investors include Louis A Cannon, MD, FACA, FACC, FACP, FSCAI, Ben Cannon.